<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Biomed Res Int</journal-id>
<journal-id journal-id-type="iso-abbrev">Biomed Res Int</journal-id>
<journal-id journal-id-type="publisher-id">BMRI</journal-id>
<journal-title-group>
<journal-title>BioMed Research International</journal-title>
</journal-title-group>
<issn pub-type="ppub">2314-6133</issn>
<issn pub-type="epub">2314-6141</issn>
<publisher>
<publisher-name>Hindawi</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32851068</article-id>
<article-id pub-id-type="pmc">7439206</article-id>
<article-id pub-id-type="doi">10.1155/2020/3978702</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Human Microbe-Disease Association Prediction by a Novel Double-Ended Random Walk with Restart</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Di</given-names>
</name>
<xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cui</surname>
<given-names>Yan</given-names>
</name>
<xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cao</surname>
<given-names>Yuxuan</given-names>
</name>
<xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Yuehan</given-names>
</name>
<xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-2771-894X</contrib-id>
<name>
<surname>Chen</surname>
<given-names>Hui</given-names>
</name>
<email>hmuhuichen@sina.com</email>
<xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="I1">
<sup>1</sup>Department of Nuclear Medicine, Harbin Medical University Cancer Hospital, Harbin, China</aff>
<aff id="I2">
<sup>2</sup>Department of Urology, Harbin Medical University Cancer Hospital, Harbin, China</aff>
<aff id="I3">
<sup>3</sup>Harbin Medical University College of Bioinformatics Science and Technology, Harbin, China</aff>
<author-notes>
<fn fn-type="other">
<p>Guest Editor: Jialiang Yang</p>
</fn>
</author-notes>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>10</day>
<month>8</month>
<year>2020</year>
</pub-date>
<volume>2020</volume>
<elocation-id>3978702</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>5</month>
<year>2020</year>
</date>
<date date-type="rev-recd">
<day>7</day>
<month>7</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>7</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2020 Di Wang et al.</copyright-statement>
<copyright-year>2020</copyright-year>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<p>Microorganisms in the human body play a vital role in metabolism, immune defense, nutrient absorption, cancer control, and prevention of pathogen colonization. More and more biological and clinical studies have shown that the imbalance of microbial communities is closely related to the occurrence and development of various complex human diseases. Finding potential microbial-disease associations is critical for understanding the pathology of a few diseases and thus further improving disease diagnosis and prognosis. In this study, we proposed a novel computational model to predict disease-associated microbes. Specifically, we first constructed a heterogeneous interconnection network based on known microbe-disease associations deposited in a few databases, the similarity between diseases, and the similarity between microorganisms. We then predicted novel microbe-disease associations by a new method called the double-ended restart random walk model (DRWHMDA) implemented on the interconnection network. In addition, we performed case studies of colon cancer and asthma for further evaluation. The results indicate that 10 and 9 of the top 10 microorganisms predicted to be associated with colorectal cancer and asthma were validated by relevant literatures, respectively. Our method is expected to be effective in identifying disease-related microorganisms and will help to reveal the relationship between microorganisms and complex human diseases.</p>
</abstract>
<funding-group>
<award-group>
<funding-source>Heilongjiang Postdoctoral Financial Assistance</funding-source>
<award-id>LBH-Z16216</award-id>
</award-group>
<award-group>
<funding-source>Wu Jieping Medical Foundation</funding-source>
<award-id>320.6750.17107</award-id>
</award-group>
<award-group>
<funding-source>Harbin Medical University Cancer Hospital</funding-source>
<award-id>JJMS2016-04</award-id>
</award-group>
<award-group>
<funding-source>Harbin Applied Technology Research and Development Project</funding-source>
<award-id>2017RAXXJ073</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
<body>
<sec id="sec1">
<title>1. Introduction</title>
<p>Microorganisms include bacteria, archaea, protozoa, fungi, and viruses. There are different types of microorganisms on the human body and in the cavity connected to the outside world, such as the oral cavity, respiratory tract, intestinal tract, and urogenital tract [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>]. Microbes play important roles in human health, metabolism, immune defense, nutrient absorption, cancer control, and prevention of colonization of pathogens [<xref ref-type="bibr" rid="B3">3</xref>]. Microorganisms of the human body are mainly distributed on the body surface, intestine, and oral cavity, and the types and numbers of microorganisms are different. Among them, the number of microorganisms in the intestine is about ten times that of the body's own cells. In nature, the density of microorganisms isolated from the colon is the highest, and 60% of the dry weight of human feces is bacteria [<xref ref-type="bibr" rid="B4">4</xref>].</p>
<p>Numerous studies have shown that many diseases are related to changes in microorganisms. For example, patients with type 2 diabetes have been found to have moderate intestinal microecological disorders and lack of butyric acid-producing bacteria [<xref ref-type="bibr" rid="B5">5</xref>]. Intestinal microbial diseases lead to intestinal immune system dysfunction. For patients with irritable bowel syndrome (IBS), the number of chronic inflammatory cells in the colonic mucosa of increases, a large number of T cells are activated, and the expression of inflammatory reactions is accelerated [<xref ref-type="bibr" rid="B6">6</xref>]. In addition, epidemiological studies have shown that common mental illnesses such as autism and schizophrenia are associated with perinatal pathogen infections [<xref ref-type="bibr" rid="B7">7</xref>–<xref ref-type="bibr" rid="B11">11</xref>].</p>
<p>As mentioned above, discovering the potential links between microbes and diseases allows us to better understand the mechanisms by which disease is formed and developed. By regulating the microbial environment, medical solutions for disease prevention, diagnosis, treatment, and prognosis can be provided to some extent. In previous biological or clinical experimental research methods, it took a lot of time and cost to obtain a new connection between microorganisms and disease. In recent years, many computational biology methods have provided new and effective tools for identifying the key links between microorganisms and disease. Ma et al. constructed a microbe-disease association data pants called HMDAD, which can help study the relationship between microbes and diseases [<xref ref-type="bibr" rid="B12">12</xref>], and provide data support for various calculation methods to predict new associations</p>
<p>In recent years, machine learning algorithms have achieved good performance in various fields [<xref ref-type="bibr" rid="B13">13</xref>]. At present, various machine learning algorithms have been used in the prediction of the association between microorganisms and diseases and have achieved good performance. As such, Chen et al. established a microorganism-human disease association network and further developed a new KATZ metric calculation model for the prediction of human microorganism-disease association (KATZHMDA) under the premise that similar-function microorganisms tend to the following assumptions [<xref ref-type="bibr" rid="B14">14</xref>]. Huang et al. [<xref ref-type="bibr" rid="B15">15</xref>] proposed a path-based human microorganism-disease association prediction (PBHMDA) method that integrates the identified nuclear-similarities of disease-microbe relationships and Gaussian interaction spectra into a heterogeneous network of diseases and microorganisms. The model traverses all possible pathways between microbes and diseases. A novel depth-first search algorithm is used to predict the microorganisms most likely to be associated with the disease. In addition, Wang et al. [<xref ref-type="bibr" rid="B16">16</xref>] proposed a new computational model of Laplace regularized least squares to reveal potential disease-related microorganisms. LRLSHMDA applies a semisupervised learning framework. In this model, a microbial similarity network and a disease similarity network are constructed based on the Gaussian interaction spectrum kernel similarity calculated from known disease-disease associations, and the cost function in the microbial space and disease space is then constructed and optimized integrating the optimal classifier function to calculate the correlation probability of microbial disease pairs. Although the reliable prediction performance of LRLSHMDA has been verified, the model still has some shortcomings and needs further improvement. For example, the number of proven microbial associations is too small, and a sparse network of known associations may affect the predictive performance of the model. Shen et al. [<xref ref-type="bibr" rid="B17">17</xref>] combined the known similarity of microbe-disease association with the nuclear similarity of the Gaussian interaction spectrum; a collaborative matrix decomposition calculation model was established for the microbial-disease association prediction (CMFHMDA) of humans and diseases. A special matrix decomposition algorithm is proposed to update the correlation matrix between microorganisms and diseases and infers the microorganisms most likely to be related to diseases. However, the performance of this model needs improvement.</p>
<p>In summary, though the tremendous progress made in computing predictions of microbial-disease associations, there are still some limitations. In order to better reveal the association between microbial diseases, based on the known heterogeneous network consisting of microbial-disease association and Gaussian interaction contour kernel similarity, we propose a computational model based on a double-ended restart random walk to predict disease-related microorganisms. To prove the superiority of the DRWHMDA algorithm, we applied the 5-fold CV and global LOOCV to evaluate the prediction performance of DRWHMDA. In addition, we used DRWHMDA for case studies of two diseases.</p>
</sec>
<sec id="sec2">
<title>2. Materials and Methods</title>
<sec id="sec2.1">
<title>2.1. Materials</title>
<p>The general workflow of DRWHMDA is shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>. First, we need to preprocess the data. The original data comes from a microbe-disease association dataset named HMDAD constructed by Ma et al. [<xref ref-type="bibr" rid="B13">13</xref>]. HMDAD contains 483 artificially planned microbiological associations involving 39 diseases and 292 microorganisms. Because there are multiple evidences for some associations, we extracted 450 different disease-microbial associations. Secondly, based on these known microbial-disease associations, we constructed disease networks, microbial networks, and microbial-disease related networks, respectively. Here, <italic>N</italic><sub><italic>d</italic></sub> = 39 indicates the number of diseases, and <italic>N</italic><sub><italic>m</italic></sub> = 292 indicates the number of microorganisms. Finally, a two-terminal random walk is performed through a heterogeneous network. Combine different prediction scores into the final associated prediction probability according to the linear combination.</p>
</sec>
<sec id="sec2.2">
<title>2.2. Symptom-Based Disease Similarity (SDM)</title>
<p>In the field of information retrieval, text documents or concepts are usually represented by feature vectors. Here, we describe the vector <italic>d</italic><sub><italic>j</italic></sub> of each disease <italic>j</italic> through symptoms. 
<disp-formula id="eq1"><label>(1)</label><mml:math id="M1"><mml:mtable><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>⋯</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>where <italic>w</italic><sub><italic>i</italic>,<italic>j</italic></sub> quantifies the strength of the association between symptom <italic>i</italic> and disease <italic>j</italic>. The prevalence of different symptoms and diseases is very different. In order to solve this heterogeneity, we do not use absolute co-occurrence <italic>w</italic><sub><italic>i</italic>,<italic>j</italic></sub> to measure the strength of the association between symptom <italic>i</italic> and disease <italic>j</italic>, but the term frequency and the reciprocal of the document frequency <italic>w</italic><sub><italic>i</italic>,<italic>j</italic></sub>. 
<disp-formula id="eq2"><label>(2)</label><mml:math id="M2"><mml:mtable><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="normal">log</mml:mi><mml:mfrac><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>where <italic>N</italic> represents the number of all diseases in the data set and <italic>n</italic><sub><italic>i</italic></sub> represents the number of diseases with symptom <italic>i</italic>.</p>
<p>Therefore, the similarity between the vectors <italic>d</italic><sub><italic>x</italic></sub> and <italic>d</italic><sub><italic>y</italic></sub> of the two diseases <italic>x</italic> and <italic>y</italic> is calculated as follows:
<disp-formula id="eq3"><label>(3)</label><mml:math id="M3"><mml:mtable><mml:mtr><mml:mtd><mml:mi mathvariant="normal">cos</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>y</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>y</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msqrt><mml:mrow><mml:msub><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:msqrt><mml:msqrt><mml:mrow><mml:msub><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>y</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:msqrt></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula></p>
<p>The cosine similarity ranges from 0 (no shared symptoms) to 1 (identical symptoms).</p>
</sec>
<sec id="sec2.3">
<title>2.3. Effect of Gaussian Interaction Spectroscopy Nuclear Similarity on Disease</title>
<p>Based on the assumption that diseases with similar phenotypes always share similar associations and nonassociative patterns with functionally similar microorganisms, the Gaussian interaction distribution kernel similarity between disease and disease can be further calculated. We define the binary vector VP(<italic>d</italic><sub><italic>i</italic></sub>) to represent the interaction curve of disease <italic>d</italic><sub><italic>i</italic></sub>, which can be obtained by observing whether <italic>d</italic><sub><italic>i</italic></sub> is known to be associated with each microorganism (i.e., the <italic>i</italic>th row of the adjacency matrix). Then, after calculating the similarity value between disease pairs, the Gaussian interaction distribution kernel similarity matrix (KD) can be constructed. 
<disp-formula id="eq4"><label>(4)</label><mml:math id="M4"><mml:mtable><mml:mtr><mml:mtd><mml:mtext>KD</mml:mtext><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mi mathvariant="normal">exp</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mfenced close="|" open="|"><mml:mrow><mml:mfenced close="|" open="|"><mml:mrow><mml:mtext>VP</mml:mtext><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>−</mml:mo><mml:mi>V</mml:mi><mml:mi>P</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfenced></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula><disp-formula id="EEq4"><label>(5)</label><mml:math id="EEq4EAAAACDDCA"><mml:mtable><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>γ</mml:mi><mml:msub><mml:mrow><mml:mo>′</mml:mo></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>/</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:mfrac><mml:munderover><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:msup><mml:mrow><mml:mfenced close="|" open="|"><mml:mrow><mml:mfenced close="|" open="|"><mml:mrow><mml:mtext>VP</mml:mtext><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:mfenced></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula></p>
<p>The parameter value <italic>γ</italic><sub><italic>d</italic></sub> controls the bandwidth of the Gaussian kernel. As shown in (<xref ref-type="disp-formula" rid="EEq4">5</xref>), <italic>γ</italic>′<sub><italic>d</italic></sub> can be further calculated by dividing the new bandwidth parameter <italic>γ</italic>′<sub><italic>d</italic></sub>. The average of each disease is associated with microorganisms. Here, we <italic>γ</italic>′<sub><italic>d</italic></sub> = 1 according to previous research [<xref ref-type="bibr" rid="B18">18</xref>].</p>
<p>From the above, we can see that the similarity of the Gaussian interaction spectrum kernel is only based on adjacency matrix <italic>A</italic>. If we want to effectively and scientifically predict potential disease-related microorganisms, it is necessary to incorporate other data sets similar to the Gaussian interaction spectrum kernel, recorded in PubMed bibliography based on disease and corresponding symptoms. Zhou et al. (2014) calculated similarities between diseases and established a symptom-based human disease network (HSDN). Here, we synthesize the Gaussian interaction spectrum kernel similarity of disease KD and symptom-based disease similarity SDM to obtain symptom-based disease similarity SD, and SD is calculated as follows:
<disp-formula id="eq5"><label>(6)</label><mml:math id="M5"><mml:mtable><mml:mtr><mml:mtd><mml:mtext>SD</mml:mtext><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mtext>KD</mml:mtext><mml:mo>+</mml:mo><mml:mtext>SDM</mml:mtext></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula></p>
</sec>
<sec id="sec2.4">
<title>2.4. Gaussian Interaction Spectrum Nuclear Similarity for Microbes</title>
<p>In the same way, the Gaussian interaction similarity <italic>m</italic><sub><italic>i</italic></sub> and <italic>m</italic><sub><italic>j</italic></sub> between microorganisms can be obtained as the Gaussian kernel similarity matrix (KM) between microorganisms. 
<disp-formula id="eq6"><label>(7)</label><mml:math id="M6"><mml:mtable><mml:mtr><mml:mtd><mml:mtext>KM</mml:mtext><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mi mathvariant="normal">exp</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mtext>m</mml:mtext></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mfenced close="|" open="|"><mml:mrow><mml:mfenced close="|" open="|"><mml:mrow><mml:mtext>VP</mml:mtext><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>−</mml:mo><mml:mtext>VP</mml:mtext><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mo>′</mml:mo></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mi>n</mml:mi><mml:mi>m</mml:mi><mml:msubsup><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:msup><mml:mrow><mml:mfenced close="‖" open="‖"><mml:mrow><mml:mtext>VP</mml:mtext><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>where <italic>γ</italic><sub><italic>m</italic></sub>′ is usually set to 1.</p>
</sec>
<sec id="sec2.5">
<title>2.5. Building a Heterogeneous Network</title>
<p>A heterogeneous network can be expressed as <italic>G</italic> = (<italic>D</italic>, <italic>E</italic>), where <italic>D</italic> represents 331 of all diseases and microorganisms and <italic>E</italic> represents the interaction of microorganisms and microorganisms, diseases and diseases, and diseases and microorganisms. The heterogeneous network is represented by <italic>n</italic>∗<italic>n</italic> adjacency matrix <italic>A</italic>, where <italic>n</italic> represents the number of diseases and microorganisms. By the similarity between the microorganisms (KM) and the similarity between the diseases (KD), the coefficients of similarity can construct a heterogeneity network. Then, for each adjacency matrix <italic>A</italic>, if there is an interaction between <italic>A</italic><sub><italic>i</italic></sub> and <italic>A</italic><sub><italic>j</italic></sub>, the <italic>i</italic>-th row and <italic>j</italic>-th column are set to 1, otherwise set to zero. Normalize adjacency matrix <italic>A</italic>:
<disp-formula id="eq7"><label>(8)</label><mml:math id="M7"><mml:mtable><mml:mtr><mml:mtd><mml:msubsup><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mfenced close="]" open="["><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mo>′</mml:mo></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mfenced close="]" open="["><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mfenced close="]" open="["><mml:mrow><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula></p>
</sec>
<sec id="sec2.6">
<title>2.6. Restart Random Walk Algorithm in Both Directions</title>
<p>Through heterogeneous networks, random walks are used to find potential genetic association data between diseases or microorganisms. By randomly walking to convergence, you can get the probability of a disease or microbe at every point in the heterogeneous network. The relationship between microorganisms and diseases is indicated by calculating the correlation between the probability distributions of disease and microorganisms.</p>
<p>For a disease, we list all relevant diseases and microorganisms in our known data set, and then our related diseases and microbial collections are the seeds of the disease. Among them,
<disp-formula id="eq8"><label>(9)</label><mml:math id="M8"><mml:mtable><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>dis</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mfenced close="]" open="["><mml:mrow><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mtext>dis</mml:mtext><mml:mo>¯</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mtext>dis</mml:mtext><mml:mo>¯</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>,</mml:mo></mml:mrow><mml:mrow><mml:mo>⋯</mml:mo></mml:mrow><mml:mrow><mml:mo>,</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mtext>dis</mml:mtext><mml:mo>¯</mml:mo><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msup><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula></p>
<p>Among them, the disease-related diseases and microbial aggregates <italic>ψ</italic><sub>dis¯<italic>i</italic></sub> were set to 1, and the others were set to zero. Normalize <italic>P</italic><sub>dis</sub>:
<disp-formula id="eq9"><label>(10)</label><mml:math id="M9"><mml:mtable><mml:mtr><mml:mtd><mml:mi>P</mml:mi><mml:msub><mml:mrow><mml:mo>′</mml:mo></mml:mrow><mml:mrow><mml:mtext>dis</mml:mtext><mml:mfenced close="]" open="["><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>dis</mml:mtext><mml:mfenced close="]" open="["><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>dis</mml:mtext><mml:mfenced close="]" open="["><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula></p>
<p>Similarly, we list all relevant diseases and microorganisms for a certain microbe, we know the data set, and then, we related diseases and microbial collections as <italic>P</italic><sub>mic</sub>.</p>
<p>Begin random walks and randomly access adjacent genes in each time scale (<italic>t</italic>⟶<italic>t</italic> + 1). State probability <italic>P</italic><sub><italic>t</italic>+1</sub> at time <italic>t</italic> + 1:
<disp-formula id="eq10"><label>(11)</label><mml:math id="M10"><mml:mtable><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:mfenced><mml:msup><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mo>′</mml:mo></mml:mrow></mml:msup><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>r</mml:mi><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>where <italic>P</italic><sub><italic>t</italic></sub> is the probability of time <italic>t</italic> and <italic>r</italic> is the probability of restart. According to previous studies, we set <italic>r</italic> to 0.7 [<xref ref-type="bibr" rid="B19">19</xref>]. If the difference between <italic>P</italic><sub><italic>t</italic></sub> and <italic>P</italic><sub><italic>t</italic>+1</sub> is less than 10<sup>−6</sup> used in the previous study, the process will reach a steady state [<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>]. By using the mapped set <italic>P</italic><sub>dis</sub> as the seed of the disease and the mapped set <italic>P</italic><sub>mic</sub> as the seed of the microbe, we implemented a two-way random walk algorithm to obtain the association probability score<sub><italic>d</italic></sub> with disease as the random seed and the association probability score<sub><italic>m</italic></sub> with microorganism as the random seed. The association probability score between the disease <italic>d</italic><sub><italic>i</italic></sub> and the microorganism <italic>m</italic><sub><italic>i</italic></sub> is finally obtained by linearly combining the two predicted probabilities. 
<disp-formula id="eq11"><label>(12)</label><mml:math id="M11"><mml:mtable><mml:mtr><mml:mtd><mml:mtext>Score</mml:mtext><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi><mml:mtext>score</mml:mtext></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>β</mml:mi></mml:mrow></mml:mfenced><mml:msub><mml:mrow><mml:mtext>score</mml:mtext></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>where <italic>β</italic> represents the parameter of the linear combination; we set the default value to 0.7.</p>
</sec>
</sec>
<sec id="sec3">
<title>3. Results</title>
<sec id="sec3.1">
<title>3.1. Performance Evaluation</title>
<p>To verify the predictive performance of DRWHMDA, we implemented 5-fold CV and global LOOCV on the model based on the HMDAD database. In each 5-fold CV, the known correlation matrix <italic>Y</italic> is divided into 5-folds; then each fold is taken as a test set, and the remaining 4 folds are treated as a training set. On the other hand, in the global LOOCV, each known microbial-disease association is sequentially excluded from the test, and other microbial-disease associations are used as training samples for model learning. Specifically, all microbial-disease pairs without known evidence of correlation will be considered candidate samples. Further obtain the rank of each missing test sample relative to the candidate sample. Test samples with a prediction level above a given threshold will be considered to have successfully predicted. We evaluated the predictive performance of the model based on the AUC value of the area under the curve of the receiver. Specifically, only test samples ranked above a certain threshold can be considered correct predictions. We then set the true-positive rate (TPR, sensitivity) and false-positive rate (FPR, 1 − specificity) as the horizontal axis and the vertical axis, respectively. Therefore, we can draw a receiver operating characteristic (ROC) curve composed of points corresponding to different thresholds and then obtain the area (AUC) under the ROC curve. A model with an AUC value equal to 0.5 is equivalent to random prediction. When the AUC takes a maximum of 1, the model has excellent prediction performance. In other words, when the value of AUC is greater than 0.5 and less than 1, the larger the value is, the better the prediction performance of the model.</p>
<p>As shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>, the 5-fold CV value of DRWHMDA was 0.8676, which was significantly larger than those of KATZHMDA (0.8382), LRLSHMDA (0.8493), and ABHMDA (0.8571). What was more, the global LOOCV value of our model reached 0.8897, which was also obviously better than those of KATZHMDA (0.8644), LRLSHMDA (0.8843), and ABHMDA (0.8861). These results confirmed the superior prediction performance of DRWHMDA.</p>
<p>To investigate the selection of restart probability <italic>r</italic> for the performance of DRWHMDA, we set various values of <italic>r</italic> ranging from 0.1 to 0.9 and calculated AUC in the framework of 5-fold CV. As shown in <xref ref-type="table" rid="tab1">Table 1</xref>, as the restart probability r gradually increases, the prediction performance obtained through DRWHMDA increases first and then decreases.</p>
</sec>
<sec id="sec3.2">
<title>3.2. Case Study</title>
<p>In the present study, double-ended random walks were used to screen candidate microorganisms for all the investigated diseases. To further evaluate the predictive performance of DRWHMDA, we included 10,038 unknown samples in HMDAD, involving 39 diseases and 292 microorganisms. The corresponding unknown samples are classified and ranked by the DRWHMDA algorithm, and it is verified whether the relevant literature has verified the association between the top ten microorganisms and the disease under study. Among them, an independent case analysis was performed on colon cancer and asthma.</p>
</sec>
<sec id="sec3.3">
<title>3.3. Relationship between Colon Cancer and Microorganisms</title>
<p>According to previous research, the intestinal microflora is the most complex, and it is most closely related to various behavioral diseases in humans. Imbalance of the human intestinal microbial flora can lead to autoimmune diseases [<xref ref-type="bibr" rid="B22">22</xref>], obesity [<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>], inflammatory bowel disease (IBD) [<xref ref-type="bibr" rid="B25">25</xref>], diabetes [<xref ref-type="bibr" rid="B26">26</xref>], and even cancer [<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>]. According to the world's leading cancer statistics report, colon cancer has been a high-risk area for men and women over the past few decades [<xref ref-type="bibr" rid="B29">29</xref>]. Therefore, it is necessary to study the pathogenesis of colon cancer in order to explore new treatment methods. More and more evidences show that the imbalance of microbial community is closely related to the occurrence and development of colon cancer. For example, in the sequence analysis of 16S rRNA gene V3 region in patients with sporadic colorectal cancer, the protein bacteria are insufficient [<xref ref-type="bibr" rid="B30">30</xref>]; Staphylococcus produces tannase; its activity may be related to the development of colon cancer [<xref ref-type="bibr" rid="B31">31</xref>]. Compared with noncancerous tissues, Lactococcus and Fusarium are more abundant in cancerous tissues, and Pseudomonas and Escherichia coli are less abundant [<xref ref-type="bibr" rid="B32">32</xref>]. We applied DRWHMDA to the first case study of colon cancer. Of the top 10 predicted microorganisms, 9 have been validated based on recent experimental literature (see <xref ref-type="table" rid="tab2">Table 2</xref>). Evidence suggests that Clostridium difficile- (first in the prediction list) associated colitis is a known complication of colon and rectal surgery and can increase morbidity and mortality during surgery, thereby increasing hospital stay time and costs [<xref ref-type="bibr" rid="B33">33</xref>].</p>
</sec>
<sec id="sec3.4">
<title>3.4. The Relationship between Asthma and Microbes</title>
<p>Asthma is a common chronic inflammatory disease of the lungs and is generally thought to be caused by a combination of genetic and environmental factors. According to the latest statistics, the incidence of asthma has been rising in recent decades, with the number of asthma patients increasing from 183 million in 1990 to 242 million in 2013. Infection by pathogenic microorganisms (especially viruses, chlamydia, mycoplasma, and mold) is one of the main causes of severe asthma [<xref ref-type="bibr" rid="B34">34</xref>–<xref ref-type="bibr" rid="B37">37</xref>]. For example, studies have shown that Proteus accounts for a higher proportion of microorganisms in asthma patients and that Firmicutes are reduced in asthma patients compared to normal people. Moreover, there is evidence that when the hypopharyngeal area of a newborn is infected with Streptococcus pneumoniae, the risk of developing asthma is increased compared to uninfected [<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B39">39</xref>]. Therefore, research on asthma-related microorganisms is crucial and will help us to gain a deeper understanding of the pathogenesis and treatment of asthma. Prioritizing candidate microorganisms by implementing DRWHMDA, recent clinical evidence successfully validated 9 of the top 10 predicted microorganisms (see <xref ref-type="table" rid="tab3">Table 3</xref>). As for the top five confirmed asthma-associated microorganisms, Clostridium difficile and Staphylococcus aureus (No. 1 and No. 5 in the prediction table) were found to be increased in number in airway concentrations in asthma patients, while Firmicutes and Actinomycetes were found to be reduced [<xref ref-type="bibr" rid="B40">40</xref>]. Importantly, the XIVa subclass of Clostridium globosum (No. 3 in the prediction table) has been proven to be an early indicator of future asthma, help prevent and diagnose asthma, and provide guidance for clinical treatment.</p>
<p>For clarity, we illustrate in <xref ref-type="fig" rid="fig3">Figure 3</xref> the association network of the top 10 predicted microbial candidates for two diseases. It is worth noting that some top candidates were found to be related to several diseases. For example, both Fermicket and Clostridium have been documented to prove that they are related to the occurrence of asthma and colon cancer at the same time.</p>
</sec>
</sec>
<sec id="sec4">
<title>4. Discussion</title>
<p>Over the years, a lot of evidence has shown that microorganisms living in the human body are closely related to human life activities and human diseases. Abnormal levels of specific microorganisms are closely related to the development of various human diseases. Microbial disease-related knowledge can provide valuable insights into understanding complex disease mechanisms and preventing, diagnosing, and treating various diseases. However, little work has been done to predict microbial candidates for large-scale human complex diseases. Therefore, in this paper, a computational model based on known microbial-disease correlation is proposed. A microbial similarity network and a disease similarity network are constructed using Gaussian kernel similarity. Using the existing experimentally validated associations, we connected the two networks. The double-ended restart random walk method is used to walk on the network, and the correlation probability order representing the candidate microorganism-disease association is obtained. The construction network with different correlations is applied to the optimization of prediction performance, and the optimal prediction parameters are obtained. The results show that DRWHMDA achieved average AUC reliability performance of 0.8676 and 0.8897 in the 5-fold cross-validation and LOOCV framework, respectively. Given its good predictive performance, we believe that the model can be used as one of the effective tools to accelerate biomedical identification of underlying disease-related microorganisms.</p>
<p>Although DRWHMDA has achieved satisfactory results, this method still has some limitations. First, we only use Gaussian kernel similarity to construct a similarity network which is too simplistic. Improving the predictive performance of DRWHMDA by integrating disease or microbe similarity from multiple data sources (such as sequence similarity) may help. Secondly, as more and more microbes and disease associations are identified, collecting more validated data will help us conduct further research. Finally, we experimentally verify candidate microbes related to the disease, and some have not been verified in the literature, because the verification of these candidate microbes through biological wet experiments will also be one of the important directions for our subsequent research.</p>
</sec>
<sec id="sec5">
<title>5. Conclusion</title>
<p>The main goal of the current research is to predict the microorganisms that may be related to the disease through the calculation method, thereby reducing the verification cost of the biological wet experiment, so that people can more deeply explore the impact of microorganisms on human complex diseases. Therefore, this paper proposes a calculation model of microbial disease correlation based on double-ended random walk. The results show that DRWHMDA has achieved more reliable and stable prediction performance than other algorithms. We believe that the model can be used as one of the effective tools for accelerating biomedical identification of potential disease-related microorganisms.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>This research was funded by the Harbin Applied Technology Research and Development Project (grant no. 2017RAXXJ073), Hai Yan Foundation of Harbin Medical University Cancer Hospital (grant no. JJMS2016-04), Wu Jieping Medical Foundation Technology Research Project (grant no. 320.6750.17107), and Heilongjiang Postdoctoral Financial Assistance (LBH-Z16216).</p>
</ack>
<sec sec-type="data-availability">
<title>Data Availability</title>
<p>The database used in this study was downloaded from the Human Microbe-Disease Association Database (HMDAD, <ext-link ext-link-type="uri" xlink:href="http://www.cuilab.cn/hmdad">http://www.cuilab.cn/hmdad</ext-link>).</p>
</sec>
<sec sec-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no competing interests.</p>
</sec>
<sec>
<title>Authors' Contributions</title>
<p>Di Wang and Hui Chen conceived the concept of the work. Yan Cui, Yuxuan Cao, and Yuehan He performed the experiments. Yan Cui and Di Wang wrote the paper. All authors approved the final version of this manuscript. Di Wang and Yan Cui contributed equally to this work.</p>
</sec>
<ref-list>
<ref id="B1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ventura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>O'Flaherty</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Claesson</surname>
<given-names>M. J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-scale analyses of health-promoting bacteria: probiogenomics</article-title>
<source/>
<italic toggle="yes">Nature Reviews. Microbiology</italic>
<year>2009</year>
<volume>7</volume>
<issue>1</issue>
<fpage>61</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro2047</pub-id>
<pub-id pub-id-type="other">2-s2.0-57649184474</pub-id>
<pub-id pub-id-type="pmid">19029955</pub-id>
</element-citation>
</ref>
<ref id="B2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costello</surname>
<given-names>E. K.</given-names>
</name>
<name>
<surname>Lauber</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Hamady</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fierer</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>J. I.</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Bacterial community variation in human body habitats across space and time</article-title>
<source/>
<italic toggle="yes">Science</italic>
<year>2009</year>
<volume>326</volume>
<issue>5960</issue>
<fpage>1694</fpage>
<lpage>1697</lpage>
<pub-id pub-id-type="doi">10.1126/science.1177486</pub-id>
<pub-id pub-id-type="other">2-s2.0-72949091232</pub-id>
<pub-id pub-id-type="pmid">19892944</pub-id>
</element-citation>
</ref>
<ref id="B3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Nair</surname>
<given-names>G. B.</given-names>
</name>
</person-group>
<article-title>Homeostasis and dysbiosis of the gut microbiome in health and disease</article-title>
<source/>
<italic toggle="yes">Journal of Biosciences</italic>
<year>2019</year>
<volume>44</volume>
<issue>5</issue>
<fpage>p. 44(5)</fpage>
<pub-id pub-id-type="doi">10.1007/s12038-019-9926-y</pub-id>
<pub-id pub-id-type="other">2-s2.0-85073220817</pub-id>
</element-citation>
</ref>
<ref id="B4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pickard</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Caruso</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Núñez</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease</article-title>
<source/>
<italic toggle="yes">Immunological Reviews</italic>
<year>2017</year>
<volume>279</volume>
<issue>1</issue>
<fpage>70</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="doi">10.1111/imr.12567</pub-id>
<pub-id pub-id-type="other">2-s2.0-85028562926</pub-id>
<pub-id pub-id-type="pmid">28856738</pub-id>
</element-citation>
</ref>
<ref id="B5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>Z.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A metagenome-wide association study of gut microbiota in type 2 diabetes</article-title>
<source/>
<italic toggle="yes">Nature</italic>
<year>2012</year>
<volume>490</volume>
<issue>7418</issue>
<fpage>55</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1038/nature11450</pub-id>
<pub-id pub-id-type="other">2-s2.0-84867074831</pub-id>
<pub-id pub-id-type="pmid">23023125</pub-id>
</element-citation>
</ref>
<ref id="B6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pimentel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chow</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>H. C.</given-names>
</name>
</person-group>
<article-title>Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome</article-title>
<source/>
<italic toggle="yes">The American Journal of Gastroenterology</italic>
<year>2000</year>
<volume>95</volume>
<issue>12</issue>
<fpage>3503</fpage>
<lpage>3506</lpage>
<pub-id pub-id-type="doi">10.1111/j.1572-0241.2000.03368.x</pub-id>
<pub-id pub-id-type="pmid">11151884</pub-id>
</element-citation>
</ref>
<ref id="B7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mittal</surname>
<given-names>V. A.</given-names>
</name>
<name>
<surname>Ellman</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Cannon</surname>
<given-names>T. D.</given-names>
</name>
</person-group>
<article-title>Gene-environment interaction and covariation in schizophrenia: the role of obstetric complications</article-title>
<source/>
<italic toggle="yes">Schizophrenia Bulletin</italic>
<year>2008</year>
<volume>34</volume>
<issue>6</issue>
<fpage>1083</fpage>
<lpage>1094</lpage>
<pub-id pub-id-type="doi">10.1093/schbul/sbn080</pub-id>
<pub-id pub-id-type="other">2-s2.0-54249162304</pub-id>
<pub-id pub-id-type="pmid">18635675</pub-id>
</element-citation>
</ref>
<ref id="B8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finegold</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Molitoris</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gastrointestinal microflora studies in late-onset autism</article-title>
<source/>
<italic toggle="yes">Clinical Infectious Diseases</italic>
<year>2002</year>
<volume>35</volume>
<issue>Suppl 1</issue>
<fpage>S6</fpage>
<lpage>s16</lpage>
<pub-id pub-id-type="doi">10.1086/341914</pub-id>
<pub-id pub-id-type="other">2-s2.0-0036061028</pub-id>
<pub-id pub-id-type="pmid">12173102</pub-id>
</element-citation>
</ref>
<ref id="B9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization of fecal microbial communities in patients with liver cirrhosis</article-title>
<source/>
<italic toggle="yes">Hepatology</italic>
<year>2011</year>
<volume>54</volume>
<issue>2</issue>
<fpage>562</fpage>
<lpage>572</lpage>
<pub-id pub-id-type="doi">10.1002/hep.24423</pub-id>
<pub-id pub-id-type="other">2-s2.0-79960714764</pub-id>
<pub-id pub-id-type="pmid">21574172</pub-id>
</element-citation>
</ref>
<ref id="B10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identifying potential miRNAs–disease associations with probability matrix factorization</article-title>
<source/>
<italic toggle="yes">Frontiers in Genetics</italic>
<year>2019</year>
<volume>10</volume>
<fpage>p. 1234</fpage>
<pub-id pub-id-type="doi">10.3389/fgene.2019.01234</pub-id>
</element-citation>
</ref>
<ref id="B11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>LRMCMDA: predicting miRNA-disease association by integrating low-rank matrix completion with miRNA and disease similarity information</article-title>
<source/>
<italic toggle="yes">IEEE Access</italic>
<year>2020</year>
<volume>8</volume>
<fpage>80728</fpage>
<lpage>80738</lpage>
<pub-id pub-id-type="doi">10.1109/ACCESS.2020.2990533</pub-id>
</element-citation>
</ref>
<ref id="B12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An analysis of human microbe-disease associations</article-title>
<source/>
<italic toggle="yes">Briefings in Bioinformatics</italic>
<year>2017</year>
<volume>18</volume>
<issue>1</issue>
<fpage>85</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1093/bib/bbw005</pub-id>
<pub-id pub-id-type="other">2-s2.0-85015960685</pub-id>
<pub-id pub-id-type="pmid">26883326</pub-id>
</element-citation>
</ref>
<ref id="B13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J. L.</given-names>
</name>
</person-group>
<article-title>CMF-impute: an accurate imputation tool for single-cell RNA-seq data</article-title>
<source/>
<italic toggle="yes">Bioinformatics</italic>
<year>2020</year>
<volume>36</volume>
<issue>10</issue>
<fpage>3139</fpage>
<lpage>3147</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btaa109</pub-id>
<pub-id pub-id-type="pmid">32073612</pub-id>
</element-citation>
</ref>
<ref id="B14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y. A.</given-names>
</name>
<name>
<surname>You</surname>
<given-names>Z. H.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>G. Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X. S.</given-names>
</name>
</person-group>
<article-title>A novel approach based on KATZ measure to predict associations of human microbiota with non-infectious diseases</article-title>
<source/>
<italic toggle="yes">Bioinformatics</italic>
<year>2018</year>
<volume>34</volume>
<issue>8</issue>
<fpage>p. 1440</fpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btx773</pub-id>
<pub-id pub-id-type="other">2-s2.0-85046709702</pub-id>
</element-citation>
</ref>
<ref id="B15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>Z.-A.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Z.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PBHMDA: path-based human microbe-disease association prediction</article-title>
<source/>
<italic toggle="yes">Frontiers in Microbiology</italic>
<year>2017</year>
<volume>8</volume>
<fpage>p. 233</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2017.00233</pub-id>
<pub-id pub-id-type="other">2-s2.0-85014456581</pub-id>
</element-citation>
</ref>
<ref id="B16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Z. A.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>LRLSHMDA: Laplacian regularized least squares for human microbe-disease association prediction</article-title>
<source/>
<italic toggle="yes">Scientific Reports</italic>
<year>2017</year>
<volume>7</volume>
<issue>1</issue>
<fpage>p. 7601</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-08127-2</pub-id>
<pub-id pub-id-type="other">2-s2.0-85027182085</pub-id>
<pub-id pub-id-type="pmid">28790448</pub-id>
</element-citation>
</ref>
<ref id="B17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>CMFHMDA: Collaborative Matrix Factorization for Human Microbe-Disease Association Prediction</article-title>
<source/>
<italic toggle="yes">Intelligent Computing Theories and Application</italic>
<year>2017</year>
<pub-id pub-id-type="doi">10.1007/978-3-319-63312-1_24</pub-id>
<pub-id pub-id-type="other">2-s2.0-85027684998</pub-id>
</element-citation>
</ref>
<ref id="B18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Laarhoven</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nabuurs</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Marchiori</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Gaussian interaction profile kernels for predicting drug-target interaction</article-title>
<source/>
<italic toggle="yes">Bioinformatics</italic>
<year>2011</year>
<volume>27</volume>
<issue>21</issue>
<fpage>3036</fpage>
<lpage>3043</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btr500</pub-id>
<pub-id pub-id-type="other">2-s2.0-80054881553</pub-id>
<pub-id pub-id-type="pmid">21893517</pub-id>
</element-citation>
</ref>
<ref id="B19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes</article-title>
<source/>
<italic toggle="yes">BMC Systems Biology</italic>
<year>2013</year>
<volume>7</volume>
<issue>1</issue>
<fpage>p. 101</fpage>
<pub-id pub-id-type="doi">10.1186/1752-0509-7-101</pub-id>
<pub-id pub-id-type="other">2-s2.0-84885009161</pub-id>
</element-citation>
</ref>
<ref id="B20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hofree</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Network-based stratification of tumor mutations</article-title>
<source/>
<italic toggle="yes">Nature Methods</italic>
<year>2013</year>
<volume>10</volume>
<issue>11</issue>
<fpage>1108</fpage>
<lpage>1115</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth.2651</pub-id>
<pub-id pub-id-type="other">2-s2.0-84887084951</pub-id>
<pub-id pub-id-type="pmid">24037242</pub-id>
</element-citation>
</ref>
<ref id="B21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shyr</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Network-based stratification analysis of 13 major cancer types using mutations in panels of cancer genes</article-title>
<source/>
<italic toggle="yes">BMC Genomics</italic>
<year>2015</year>
<volume>16</volume>
<issue>Suppl 7</issue>
<fpage>p. S7</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2164-16-s7-s7</pub-id>
<pub-id pub-id-type="other">2-s2.0-84969271120</pub-id>
<pub-id pub-id-type="pmid">25923053</pub-id>
</element-citation>
</ref>
<ref id="B22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>Y. K.</given-names>
</name>
<name>
<surname>Mazmanian</surname>
<given-names>S. K.</given-names>
</name>
</person-group>
<article-title>Has the microbiota played a critical role in the evolution of the adaptive immune system?</article-title>
<source/>
<italic toggle="yes">Science</italic>
<year>2010</year>
<volume>330</volume>
<issue>6012</issue>
<fpage>1768</fpage>
<lpage>1773</lpage>
<pub-id pub-id-type="doi">10.1126/science.1195568</pub-id>
<pub-id pub-id-type="other">2-s2.0-78650647326</pub-id>
<pub-id pub-id-type="pmid">21205662</pub-id>
</element-citation>
</ref>
<ref id="B23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vijay-Kumar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aitken</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>F. A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5</article-title>
<source/>
<italic toggle="yes">Science</italic>
<year>2010</year>
<volume>328</volume>
<issue>5975</issue>
<fpage>228</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="doi">10.1126/science.1179721</pub-id>
<pub-id pub-id-type="other">2-s2.0-77950250064</pub-id>
<pub-id pub-id-type="pmid">20203013</pub-id>
</element-citation>
</ref>
<ref id="B24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abenavoli</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Scarpellini</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Colica</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota and obesity: a role for probiotics</article-title>
<source/>
<italic toggle="yes">Nutrients</italic>
<year>2019</year>
<volume>11</volume>
<issue>11</issue>
<fpage>p. 2690</fpage>
<pub-id pub-id-type="doi">10.3390/nu11112690</pub-id>
<pub-id pub-id-type="pmid">31703257</pub-id>
</element-citation>
</ref>
<ref id="B25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaakoush</surname>
<given-names>N. O.</given-names>
</name>
<name>
<surname>Day</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Huinao</surname>
<given-names>K. D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbial dysbiosis in pediatric patients with Crohn's disease</article-title>
<source/>
<italic toggle="yes">Journal of Clinical Microbiology</italic>
<year>2012</year>
<volume>50</volume>
<issue>10</issue>
<fpage>3258</fpage>
<lpage>3266</lpage>
<pub-id pub-id-type="doi">10.1128/JCM.01396-12</pub-id>
<pub-id pub-id-type="other">2-s2.0-84866463340</pub-id>
<pub-id pub-id-type="pmid">22837318</pub-id>
</element-citation>
</ref>
<ref id="B26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ley</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Volchkov</surname>
<given-names>P. Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Innate immunity and intestinal microbiota in the development of type 1 diabetes</article-title>
<source/>
<italic toggle="yes">Nature</italic>
<year>2008</year>
<volume>455</volume>
<issue>7216</issue>
<fpage>1109</fpage>
<lpage>1113</lpage>
<pub-id pub-id-type="doi">10.1038/nature07336</pub-id>
<pub-id pub-id-type="other">2-s2.0-54549122338</pub-id>
<pub-id pub-id-type="pmid">18806780</pub-id>
</element-citation>
</ref>
<ref id="B27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castellarin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>J. D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma</article-title>
<source/>
<italic toggle="yes">Genome Research</italic>
<year>2012</year>
<volume>22</volume>
<issue>2</issue>
<fpage>299</fpage>
<lpage>306</lpage>
<pub-id pub-id-type="doi">10.1101/gr.126516.111</pub-id>
<pub-id pub-id-type="other">2-s2.0-84856534859</pub-id>
<pub-id pub-id-type="pmid">22009989</pub-id>
</element-citation>
</ref>
<ref id="B28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eslami</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sadrifar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Karbalaei</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Keikha</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kobyliak</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>Yousefi</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Importance of the microbiota inhibitory mechanism on the Warburg effect in colorectal cancer cells</article-title>
<source/>
<italic toggle="yes">Journal of Gastrointestinal Cancer</italic>
<year>2019</year>
<pub-id pub-id-type="doi">10.1007/s12029-019-00329-3</pub-id>
</element-citation>
</ref>
<ref id="B29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jemal</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bray</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Center</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Ferlay</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Forman</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Global cancer statistics</article-title>
<source/>
<italic toggle="yes">CA: a Cancer Journal for Clinicians</italic>
<year>2011</year>
<volume>61</volume>
<issue>2</issue>
<fpage>69</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.3322/caac.20107</pub-id>
<pub-id pub-id-type="other">2-s2.0-79952232216</pub-id>
<pub-id pub-id-type="pmid">21296855</pub-id>
</element-citation>
</ref>
<ref id="B30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Microbiota disbiosis is associated with colorectal cancer</article-title>
<source/>
<italic toggle="yes">Frontiers in Microbiology</italic>
<year>2015</year>
<volume>6</volume>
<fpage>p. 20</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2015.00020</pub-id>
<pub-id pub-id-type="other">2-s2.0-84926436561</pub-id>
</element-citation>
</ref>
<ref id="B31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer</article-title>
<source/>
<italic toggle="yes">PLoS One</italic>
<year>2014</year>
<volume>9</volume>
<issue>3, article e90849</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0090849</pub-id>
<pub-id pub-id-type="other">2-s2.0-84897124480</pub-id>
<pub-id pub-id-type="pmid">24603888</pub-id>
</element-citation>
</ref>
<ref id="B32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noguchi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fukuzawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wajima</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Specific clones of Staphylococcus lugdunensis may be associated with colon carcinoma</article-title>
<source/>
<italic toggle="yes">Journal of Infection and Public Health</italic>
<year>2018</year>
<volume>11</volume>
<issue>1</issue>
<fpage>39</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1016/j.jiph.2017.03.012</pub-id>
<pub-id pub-id-type="other">2-s2.0-85019110236</pub-id>
<pub-id pub-id-type="pmid">28506660</pub-id>
</element-citation>
</ref>
<ref id="B33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furet</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Tap</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers</article-title>
<source/>
<italic toggle="yes">Diabetes</italic>
<year>2010</year>
<volume>59</volume>
<issue>12</issue>
<fpage>3049</fpage>
<lpage>3057</lpage>
<pub-id pub-id-type="doi">10.2337/db10-0253</pub-id>
<pub-id pub-id-type="other">2-s2.0-78650037263</pub-id>
<pub-id pub-id-type="pmid">20876719</pub-id>
</element-citation>
</ref>
<ref id="B34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dumas</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Barton</surname>
<given-names>R. H.</given-names>
</name>
<name>
<surname>Toye</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice</article-title>
<source/>
<italic toggle="yes">Proceedings of the National Academy of Sciences of the United States of America</italic>
<year>2006</year>
<volume>103</volume>
<issue>33</issue>
<fpage>12511</fpage>
<lpage>12516</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0601056103</pub-id>
<pub-id pub-id-type="other">2-s2.0-33747618036</pub-id>
<pub-id pub-id-type="pmid">16895997</pub-id>
</element-citation>
</ref>
<ref id="B35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Backhed</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The gut microbiota as an environmental factor that regulates fat storage</article-title>
<source/>
<italic toggle="yes">Proceedings of the National Academy of Sciences of the United States of America</italic>
<year>2004</year>
<volume>101</volume>
<issue>44</issue>
<fpage>15718</fpage>
<lpage>15723</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0407076101</pub-id>
<pub-id pub-id-type="other">2-s2.0-8144226856</pub-id>
<pub-id pub-id-type="pmid">15505215</pub-id>
</element-citation>
</ref>
<ref id="B36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>Y. P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J. Q.</given-names>
</name>
</person-group>
<article-title>Study of putative periodontal pathogens colonies in type 2 diabetes with chronic periodontitis</article-title>
<source/>
<italic toggle="yes">Shanghai Kou Qiang Yi Xue</italic>
<year>2010</year>
<volume>19</volume>
<issue>6</issue>
<fpage>611</fpage>
<lpage>615</lpage>
<pub-id pub-id-type="pmid">21431261</pub-id>
</element-citation>
</ref>
<ref id="B37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fermented carrot juice attenuates type 2 diabetes by mediating gut microbiota in rats</article-title>
<source/>
<italic toggle="yes">Food &amp; Function</italic>
<year>2019</year>
<volume>10</volume>
<issue>5</issue>
<fpage>2935</fpage>
<lpage>2946</lpage>
<pub-id pub-id-type="doi">10.1039/C9FO00475K</pub-id>
<pub-id pub-id-type="other">2-s2.0-85066133303</pub-id>
<pub-id pub-id-type="pmid">31070649</pub-id>
</element-citation>
</ref>
<ref id="B38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murphy</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jüllig</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Plank</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Booth</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Differential changes in gut microbiota after gastric bypass and sleeve gastrectomy bariatric surgery vary according to diabetes remission</article-title>
<source/>
<italic toggle="yes">Obesity Surgery</italic>
<year>2017</year>
<volume>27</volume>
<issue>4</issue>
<fpage>917</fpage>
<lpage>925</lpage>
<pub-id pub-id-type="doi">10.1007/s11695-016-2399-2</pub-id>
<pub-id pub-id-type="other">2-s2.0-84991067544</pub-id>
<pub-id pub-id-type="pmid">27738970</pub-id>
</element-citation>
</ref>
<ref id="B39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Long</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Steinwandel</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of oral microbiome with type 2 diabetes risk</article-title>
<source/>
<italic toggle="yes">Journal of Periodontal Research</italic>
<year>2017</year>
<volume>52</volume>
<issue>3</issue>
<fpage>636</fpage>
<lpage>643</lpage>
<pub-id pub-id-type="doi">10.1111/jre.12432</pub-id>
<pub-id pub-id-type="other">2-s2.0-85012965466</pub-id>
<pub-id pub-id-type="pmid">28177125</pub-id>
</element-citation>
</ref>
<ref id="B40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vael</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Vanheirstraeten</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Desager</surname>
<given-names>K. N.</given-names>
</name>
<name>
<surname>Goossens</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Denaturing gradient gel electrophoresis of neonatal intestinal microbiota in relation to the development of asthma</article-title>
<source/>
<italic toggle="yes">BMC Microbiology</italic>
<year>2011</year>
<volume>11</volume>
<issue>1</issue>
<fpage>p. 68</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2180-11-68</pub-id>
<pub-id pub-id-type="other">2-s2.0-79953756883</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="fig1" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>The workflow of DRWHMDA for inferring potential microbe-disease associations.</p>
</caption>
<graphic xlink:href="BMRI2020-3978702.001"></graphic>
</fig>
<fig id="fig2" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>The ROC curves for DRWHMDA and other approaches in microbe-disease association prediction for 5-fold cross-validation and global LOOCV.</p>
</caption>
<graphic xlink:href="BMRI2020-3978702.002"></graphic>
</fig>
<fig id="fig3" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<p>The network of the top 10 predicted associations for the two diseases via DRWHMDA. The dotted line indicates that it has not been confirmed by the literature.</p>
</caption>
<graphic xlink:href="BMRI2020-3978702.003"></graphic>
</fig>
<table-wrap id="tab1" orientation="portrait" position="float">
<label>Table 1</label>
<caption>
<p>Prediction AUCs of DRWHMDA at different choices of restart probability <italic>r</italic>.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">DRWHMDA</th>
<th align="center" colspan="1" rowspan="1">AUC</th>
<th align="center" colspan="1" rowspan="1">DRWHMDA</th>
<th align="center" colspan="1" rowspan="1">AUC</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>r</italic> = 0.1</td>
<td align="center" colspan="1" rowspan="1">0.8511</td>
<td align="center" colspan="1" rowspan="1">
<italic>r</italic> = 0.6</td>
<td align="center" colspan="1" rowspan="1">0.8684</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>r</italic> = 0.2</td>
<td align="center" colspan="1" rowspan="1">0.8513</td>
<td align="center" colspan="1" rowspan="1">
<italic>r</italic> = 0.7</td>
<td align="center" colspan="1" rowspan="1">0.8674</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>r</italic> = 0.3</td>
<td align="center" colspan="1" rowspan="1">0.8525</td>
<td align="center" colspan="1" rowspan="1">
<italic>r</italic> = 0.8</td>
<td align="center" colspan="1" rowspan="1">0.8666</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>r</italic> = 0.4</td>
<td align="center" colspan="1" rowspan="1">0.8597</td>
<td align="center" colspan="1" rowspan="1">
<italic>r</italic> = 0.9</td>
<td align="center" colspan="1" rowspan="1">0.8590</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>r</italic> = 0.5</td>
<td align="center" colspan="1" rowspan="1">0.8695</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="tab2" orientation="portrait" position="float">
<label>Table 2</label>
<caption>
<p>The 10 microbes predicted to be most likely to be associated with colon cancer.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Microbe</th>
<th align="center" colspan="1" rowspan="1">Evidence</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Clostridium difficile</italic>
</td>
<td align="center" colspan="1" rowspan="1">PMID:21152135</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Helicobacter pylori</italic>
</td>
<td align="center" colspan="1" rowspan="1">PMID:22294430</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Protein bacteria</italic>
</td>
<td align="center" colspan="1" rowspan="1">PMID:25699023</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Prevotella</italic>
</td>
<td align="center" colspan="1" rowspan="1">PMID:25699024</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Staphylococcus aureus</italic>
</td>
<td align="center" colspan="1" rowspan="1">Unconfirmed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Clostridium globosum</italic>
</td>
<td align="center" colspan="1" rowspan="1">PMID:18237311</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Fermicket</italic>
</td>
<td align="center" colspan="1" rowspan="1">PMID:25699024</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Bacteroides</italic>
</td>
<td align="center" colspan="1" rowspan="1">PMID:25699024</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Actinomycetes</italic>
</td>
<td align="center" colspan="1" rowspan="1">PMID:26811603</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Clostridium</italic>
</td>
<td align="center" colspan="1" rowspan="1">PMID:19807912</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="tab3" orientation="portrait" position="float">
<label>Table 3</label>
<caption>
<p>The 10 microbes predicted to be most likely to be associated with asthma.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Microbe</th>
<th align="center" colspan="1" rowspan="1">Evidence</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Clostridium difficile</italic>
</td>
<td align="center" colspan="1" rowspan="1">PMID:25974301</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Fermicket</italic>
</td>
<td align="center" colspan="1" rowspan="1">PMID:23265859</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Clostridium globosum</italic>
</td>
<td align="center" colspan="1" rowspan="1">PMID:21477358</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Actinomycetes</italic>
</td>
<td align="center" colspan="1" rowspan="1">PMID:23265859</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Staphylococcus aureus</italic>
</td>
<td align="center" colspan="1" rowspan="1">PMID:12743582</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Lactobacillus</italic>
</td>
<td align="center" colspan="1" rowspan="1">PMID:20592920</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Clostridium</italic>
</td>
<td align="center" colspan="1" rowspan="1">PMID:21477358</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Burkholder</italic>
</td>
<td align="center" colspan="1" rowspan="1">PMID:24451910</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Gracilariaceae</italic>
</td>
<td align="center" colspan="1" rowspan="1">PMID:17433177</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Lachnospiraceae</italic>
</td>
<td align="center" colspan="1" rowspan="1">PMID: 27433177</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>